24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer’s Disease: Analyses from a Clinical Trial with Nabilone

BACKGROUND: Agitation is a prevalent and difficult-to-treat symptom of Alzheimer’s disease (AD). The endocannabinoid system (ECS) has been a target of interest for the treatment of agitation. However, ECS signaling may interact with AD-related changes in brain cholesterol metabolism. Elevated brain...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Alzheimers Dis
Autors principals: Ruthirakuhan, Myuri, Herrmann, Nathan, Andreazza, Ana C., Verhoeff, Nicolaas Paul L.G., Gallagher, Damien, Black, Sandra E., Kiss, Alex, Lanctôt, Krista L.
Format: Artigo
Idioma:Inglês
Publicat: IOS Press 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6839471/
https://ncbi.nlm.nih.gov/pubmed/31322567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-190202
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars